The quote "It was the best of times, it was the worst of times," from the opening of A Tale of Two Cities by Charles Dickens is certainly appropriate for the ups and downs that the biopharma sector has experienced during 2018, particularly in the public domain where significant equity gains in the first half of the year were erased in the wake of extremely turbulent general markets that saw investors head for the sidelines.